Severe COVID-19 infection associated with endothelial activation
- PMID: 32305740
- PMCID: PMC7156948
- DOI: 10.1016/j.thromres.2020.04.014
Severe COVID-19 infection associated with endothelial activation
Comment in
-
Targeting raised von Willebrand factor levels and macrophage activation in severe COVID-19: Consider low volume plasma exchange and low dose steroid.Thromb Res. 2020 Aug;192:2. doi: 10.1016/j.thromres.2020.05.001. Epub 2020 May 5. Thromb Res. 2020. PMID: 32403033 Free PMC article. No abstract available.
-
ADAMTS13 activity, von Willebrand factor, factor VIII and D-dimers in COVID-19 inpatients.Thromb Res. 2020 Aug;192:174-175. doi: 10.1016/j.thromres.2020.05.032. Epub 2020 May 23. Thromb Res. 2020. PMID: 32505009 Free PMC article. No abstract available.
References
-
- F.A. Klok, M.J.H.A. Kruip, N.J.M. van der Meer, M.S. Arbous, D.A.M.P.J. Gommers, K.M. Kant, F.H.J. Kaptein, J. van Paassen, M.A.M. Stals, M.V. Huisman, H. Endeman, Incidence of thrombotic complications in critically ill ICU patients with COVID-19, Thromb. Res. (n.d.). doi:10.1016/j.thromres.2020.04.013. - DOI - PMC - PubMed
-
- Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020:0. doi: 10.1016/S0140-6736(20)30566-3. - DOI - PMC - PubMed
-
- Zhang Y., Xiao M., Zhang S., Xia P., Cao W., Jiang W., Chen H., Ding X., Zhao H., Zhang H., Wang C., Zhao J., Sun X., Tian R., Wu W., Wu D., Ma J., Chen Y., Zhang D., Xie J., Yan X., Zhou X., Liu Z., Wang J., Du B., Qin Y., Gao P., Qin X., Xu Y., Zhang W., Li T., Zhang F., Zhao Y., Li Y., Zhang S. Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N. Engl. J. Med. 2020 doi: 10.1056/NEJMc2007575. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
